Notice of National Cancer Institute (NCI) Participation in PAR-20-100 “Genomic Community Resources (U24 Clinical Trial Not Allowed)”

Notice Number: NOT-CA-20-027

Key Dates
Release Date: January 28, 2020

Related Announcements
PAR-20-100

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating, effective immediately, in PAR-20-100, "Genomic Community Resources (U24 Clinical Trial Not Allowed)."

The following sections of PAR-20-100 have been updated to reflect NCI's participation in this funding opportunity announcement.

Part 1. Overview Information

Components of Participating Organizations

National Human Genome Research Institute (NHGRI)

National Cancer Institute (NCI)

Catalog of Federal Domestic Assistance (CFDA) Numbers
93.172; 93.399

Funding Opportunity Purpose

NCI is interested in genomic community resources that focus on cancer.

Part 2. Section I. Funding Opportunity Description

NCI is interested in genomic community resources that focus on cancer. Note that cancer-related informatics resources are more appropriate for the NCI ITCR program (https://itcr.cancer.gov/).

Part 2. Section VII. Agency Contacts

Scientific/Research Contact
Leah Mechanic, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-6847
Email: mechanil@mail.nih.gov

Financial/Grants Management Contact
Carol Perry
National Cancer Institute (NCI)
Telephone: 240-276-6282
Email: perryc@mail.nih.gov

All other aspects of this FOA remain unchanged

Inquiries

Please direct all inquiries to:

Leah Mechanic, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-6847
Email: mechanil@mail.nih.gov